01761nam 2200433 450 991071162350332120181214191436.0(CKB)5470000002485829(OCoLC)1078951640(EXLCZ)99547000000248582920181214d2018 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierEpiPen price increases how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)Washington :U.S. Government Publishing Office,2018.1 online resource (iii, 43 pages) illustrationsS. hrg. ;114-805Includes bibliographical references.EpiPen price increases Prescription pricingUnited StatesDrugsLaw and legislationUnited StatesPharmaceutical industryUnited StatesCompetitionUnited StatesDrug delivery devicesPricesUnited StatesLegislative hearings.lcgftPrescription pricingDrugsLaw and legislationPharmaceutical industryCompetitionDrug delivery devicesPricesGPOGPOBOOK9910711623503321EpiPen price increases3528170UNINA